Global Ischemic Heart Disease (IHD) Drugs Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Ischemic Heart Disease (IHD) Drugs Market from 2024 to 2033?
The ischemic heart disease (IHD) drugs market is growing strongly, projected to increase from $6.02 billion in 2023 to $6.36 billion in 2024 at a CAGR of 5.7%. This rise is driven by the global prevalence of IHD, enhanced diagnostics, lifestyle changes, cardiovascular health initiatives, and improved insurance policies.
The ischemic heart disease (IHD) drugs market is expected to grow to $7.57 billion by 2028, at a CAGR of 4.4%. Contributing factors include an aging population, personalized medicine approaches, a focus on cardiovascular prevention, global health policies, and international research collaborations. Major trends include a shift toward precision medicine, novel anti-atherogenic agents, advancements in lipid-lowering therapies, anti-inflammatory agents, and the development of antithrombotic and antiplatelet drugs.
Claim Your Free Sample of the Global Ischemic Heart Disease (IHD) Drugs Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13467&type=smp
What Key Factors Are Fueling the Growth of the Ischemic Heart Disease (IHD) Drugs Market?
The rising prevalence of obesity and diabetes is expected to drive the ischemic heart disease (IHD) drugs market. Obesity and diabetes are significant risk factors for ischemic heart disease, and drugs are used to manage cardiovascular risks. The World Obesity Federation forecasted in March 2023 that obesity rates would double among boys and increase by 125% among girls by 2035, while the International Diabetes Federation predicted 643 million people will be affected by diabetes by 2030, propelling the growth of the IHD drugs market.
What Are the Major Segments of the Ischemic Heart Disease (IHD) Drugs Market?
1) By Drug Class: Anti-Dyslipidemic Drugs, Calcium Channel Blockers, Beta-Blockers, Angiotensin-converting enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Vasodilators, Antithrombotic Agents
2) By Disease Class: Angina Pectoris, Myocardial Infarction
3) By End User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
What New Trends Are Transforming the Ischemic Heart Disease (IHD) Drugs Market?
In the ischemic heart disease (IHD) drugs market, companies are focusing on developing platelet inhibitors, such as intravenous P2Y12 platelet inhibitors. For example, in October 2021, MSN Laboratories launched CANREAL injection (Cangrelor), an intravenous P2Y12 platelet inhibitor used during percutaneous coronary interventions. It offers rapid onset and offset of platelet inhibition, reducing the risk of myocardial infarction and providing a bioequivalent generic solution for patients.
Order Now for Fast Delivery of Your Ischemic Heart Disease (IHD) Drugs Market Report!
Which Regions Are Driving Growth in the Ischemic Heart Disease (IHD) Drugs Market?
North America was the largest region in the ischemic heart disease (IHD) drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ischemic heart disease (ihd) drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Ischemic Heart Disease (IHD) Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the ischemic heart disease (ihd) drugs market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Ischemic Heart Disease (IHD) Drugs Market Include
1. Ischemic Heart Disease (IHD) Drugs Market Executive Summary
2. Ischemic Heart Disease (IHD) Drugs Market Segments
3. Ischemic Heart Disease (IHD) Drugs Market Size And Template Market Growth Rate
4. Key Ischemic Heart Disease (IHD) Drugs Market Trends
5. Major Ischemic Heart Disease (IHD) Drugs Market Drivers
……
25. Key Mergers And Acquisitions In The Ischemic Heart Disease (IHD) Drugs Market
26. Top Ischemic Heart Disease (IHD) Drugs Companies
27. Ischemic Heart Disease (IHD) Drugs Market Opportunities And Strategies
28. Ischemic Heart Disease (IHD) Drugs Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Antiparasitic Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report
Congenital Diaphragmatic Hernia Drugs Global Market Report 2024
Complicated Skin And Skin Structure Infections Drugs Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
